TABLE OF CONTENTS
Volume 26, Issue 4 (25 January 2007)
Original Articles
HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination
C Nakai-Murakami, M Shimura, M Kinomoto, Y Takizawa, K Tokunaga, T Taguchi, S Hoshino, K Miyagawa, T Sata, H Kurumizaka, A Yuo and Y Ishizaka
Oncogene 26: 477-486; advance online publication, September 18, 2006; doi:10.1038/sj.onc.1209831
Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation
K W Jeong, H-Z Kim, S Kim, Y S Kim and J Choe
Oncogene 26: 487-499; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209837
Smad3 is acetylated by p300/CBP to regulate its transactivation activity
Y Inoue, Y Itoh, K Abe, T Okamoto, H Daitoku, A Fukamizu, K Onozaki and H Hayashi
Oncogene 26: 500-508; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209826
RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene
T Eguchi, T Takaki, H Itadani and H Kotani
Oncogene 26: 509-520; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209810
Akt regulates nuclear/cytoplasmic localization of tuberin
M Rosner, A Freilinger and M Hengstschläger
Oncogene 26: 521-531; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209812
Novel roles of NM23 proteins in skin homeostasis, repair and disease
S Braun, C Mauch, P Boukamp and S Werner
Oncogene 26: 532-542; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209822
Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions
S R Oakes, F G Robertson, J G Kench, M Gardiner-Garden, M P Wand, J E Green and C J Ormandy
Oncogene 26: 543-553; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209838
Simultaneous downregulation of CDK inhibitors p18Ink4c and p27Kip1 is required for MEN2A-RET-mediated mitogenesis
P P Joshi, M V Kulkarni, B K Yu, K R Smith, D L Norton, W van Veelen, J W M Höppener and D S Franklin
Oncogene 26: 554-570; advance online publication, September 4, 2006; doi:10.1038/sj.onc.1209811
NF-
B-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition
K La Ferla-Brühl, M A Westhoff, S Karl, H Kasperczyk, R M Zwacka, K M Debatin and S Fulda
Oncogene 26: 571-582; advance online publication, August 7, 2006; doi:10.1038/sj.onc.1209841
Downregulation of RUNX3 and TES by hypermethylation in glioblastoma
W Mueller, C L Nutt, M Ehrich, M J Riemenschneider, A von Deimling, D van den Boom and D N Louis
Oncogene 26: 583-593; advance online publication, August 14, 2006; doi:10.1038/sj.onc.1209805
IFITM1 plays an essential role in the antiproliferative action of interferon-
G Yang, Y Xu, X Chen and G Hu
Oncogene 26: 594-603; advance online publication, July 17, 2006; doi:10.1038/sj.onc.1209807
Short Communication
HIF-1
and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases
S Paltoglou and B J Roberts
Oncogene 26: 604-609; advance online publication, August 21, 2006; doi:10.1038/sj.onc.1209818
Oncogenomics
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin–proteasome pathway as a therapeutic target in poor prognosis tumors
A C Borczuk, G C A Cappellini, H K Kim, M Hesdorffer, R N Taub and C A Powell
Oncogene 26: 610-617; advance online publication, July 24, 2006; doi:10.1038/sj.onc.1209809
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p
N A L Cody, V Ouellet, E N Manderson, M C J Quinn, A Filali-Mouhim, P Tellis, M Zietarska, D M Provencher, A-M Mes-Masson, M Chevrette and P N Tonin
Oncogene 26: 618-632; advance online publication, August 7, 2006; doi:10.1038/sj.onc.1209821
